Amphenol Corporation filings document the company’s operating results, capital structure, governance and material-event disclosures as a global supplier of connectors, interconnect systems, antennas, sensors and specialty cable products. Form 8-K reports cover quarterly and annual financial results, completed acquisition activity, material agreements, debt offerings and board succession matters.
APH proxy materials address director elections, executive compensation, auditor ratification, stockholder voting procedures and beneficial ownership. Registration and current-report filings also disclose Class A common stock, listed senior notes, unsecured note guarantees by Amphenol, subsidiary financing activity, risk factors and other corporate governance and capital-allocation matters.
Amended Form 4 for APH reporting correction to prior insider filing. The filing shows that on 08/18/2025 the reporting person disposed of 76,400 shares of Class A common stock. Following the reported transactions the reporting person beneficially owns 25,000 shares indirectly through a 2025 GRAT #1 and 0 shares indirectly through a 2024 Irrevocable Trust. The amendment states a previously filed Form 4 (filed 08/19/2025) incorrectly reported that the 2024 Irrevocable Trust beneficially owned non-derivative securities; this amendment corrects the beneficial ownership amounts. The form is signed by Lance E. D'Amico and identifies his role as Sr. VP, Secretary & General Counsel of Amphenol Corporation.
Amphenol (APH) insider changes: Senior VP, Human Resources David M. Silverman reported transactions dated 08/25/2025. He exercised 100,000 stock options with an exercise price of $18.23 (options issued 05/19/2018, expiring 05/19/2027) and thereby acquired 100,000 Class A shares. On the same date he sold 100,000 Class A shares at a weighted average sale price of $110.4203 (trades ranged $109.90 to $110.59). Following the reported transactions the filing shows 12,500 Class A shares beneficially owned directly and 14,000 Class A shares indirectly through the 2025 GRAT #1.
Amphenol Corporation (APH) furnished an 8-K disclosing that it entered two credit facilities on August 22, 2025: a Three-Year Term Loan Credit Agreement and a 364-Day Term Loan Credit Agreement, each among the company, certain subsidiaries, a syndicate of financial institutions and JPMorgan Chase Bank, N.A. as administrative agent. The filing lists these agreements as Exhibits 10.1 and 10.2 and includes an interactive data cover page. The form is signed by Craig A. Lampo, Senior Vice President and Chief Financial Officer, on August 25, 2025.
These exhibits indicate new or replaced borrowing arrangements were executed, but the filing text provided here does not disclose loan amounts, pricing, covenants, maturity details beyond the term lengths, or use of proceeds. Without those specifics, the precise financial impact on liquidity, leverage, or interest expense cannot be determined from this extract alone.
Form 144 filed for Amphenol Corporation (APH) shows a proposed sale of 100,000 common shares through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $11,042,030.00 and reported shares outstanding of 1,220,921,111. The filing states the securities were acquired by exercise of options under a registered plan on 08/25/2025 and payment was in cash. The document also lists a sale by David Silverman of 100,000 common shares on 05/30/2025 that generated $8,909,350.00 in gross proceeds. The filer affirms no undisclosed material adverse information and includes the standard Rule 144 representations and signature warning regarding intentional misstatements.
Form 144 notice for Amphenol Corporation (APH) reporting a proposed sale of 40,076 common shares through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $4,430,602.18. The filing shows those shares were acquired and paid for on 08/25/2025 via exercise of options under a registered plan and paid in cash. The form also discloses a prior sale by the same person, Craig Lampo, of 199,848 common shares on 08/22/2025 generating gross proceeds of $22,069,674.29. The filer certifies there is no undisclosed material adverse information and includes the standard Rule 144 and 10b5-1 representations.
Craig A. Lampo, Senior VP & CFO of Amphenol Corporation (APH), reported transactions on 08/22/2025. He exercised stock options totaling 199,848 shares at an exercise price of $21.995 per share and immediately sold 199,848 shares at a weighted average sale price of $110.4323 per share (trades ranged from $109.55 to $110.94). The Form 4 discloses the option exercise date as 08/22/2025 with the underlying option grant dated 05/18/2019 and an expiration of 05/18/2028.
After these reported transactions, the filing shows the reporting person beneficially owned 325,543 shares directly or indirectly, including specific indirect holdings: 58,116 shares in a 2025 GRAT #1, 74,305 in a 2024 GRAT #1, 160,000 in a 2024 GRAT #2, and 39,884 in the Lampo Family Trust. The filing was signed by a POA on 08/25/2025.
Amphenol Corporation (APH) Form 144 shows a proposed sale of 199,848 common shares through Morgan Stanley Smith Barney on the NYSE with an approximate sale date of 08/22/2025. The filing reports an aggregate market value of $22,069,674.29 and total shares outstanding of 1,220,921,111. The shares were recorded as acquired on 08/22/2025 by exercise of options under a registered plan and paid for in cash the same date. The filing notes "Nothing to Report" for securities sold in the past three months. Filer identity fields (CIK/CCC and contact details) are not populated in the provided content.
Lance E. D'Amico, Sr. VP, Secretary & General Counsel of Amphenol Corporation (APH), reported multiple transactions on 08/18/2025. The filing shows exercises of stock options and contemporaneous open-market sales. The reporting person exercised a 100,000-share option at an exercise price of $22.5525 and a 30,000-share option at $22.3725. On the same date the filing reports sales of 100,000 and 30,000 Class A common shares at weighted-average prices of approximately $110.6003 and $110.8083, respectively. The Form 4 indicates various direct and indirect beneficial ownership figures after these transactions, including a reported 25,000 shares indirectly held in a 2025 GRAT.
Amphenol Corporation (APH) Form 144 notifies the SEC of a proposed sale of 30,000 common shares through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $3,324,249.00. The filing states the shares were acquired and are to be sold on 08/18/2025 via exercise of options under a registered plan and paid for in cash. The issuer's total shares outstanding listed in the form are 1,220,921,111, and there were no reported sales in the past three months for this account. The filer represents there is no undisclosed material adverse information.
Amphenol Corporation (APH) Form 144 notifies the SEC of a proposed sale of 30,000 common shares through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $3,324,249.00. The filing states the shares were acquired and are to be sold on 08/18/2025 via exercise of options under a registered plan and paid for in cash. The issuer's total shares outstanding listed in the form are 1,220,921,111, and there were no reported sales in the past three months for this account. The filer represents there is no undisclosed material adverse information.
Amphenol Corporation (APH) filed a Form 144 reporting a proposed sale of 100,000 common shares by a person who acquired those shares via exercise of options under a registered plan on 08/18/2025. The filing shows the sale is to be executed through Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value of $11,060,030.00 and a reported outstanding share count of 1,220,921,111. The filer states no securities were sold by the same person in the past three months and certifies lack of undisclosed material adverse information.
Amphenol Corporation (APH) filed a Form 144 reporting a proposed sale of 100,000 common shares by a person who acquired those shares via exercise of options under a registered plan on 08/18/2025. The filing shows the sale is to be executed through Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value of $11,060,030.00 and a reported outstanding share count of 1,220,921,111. The filer states no securities were sold by the same person in the past three months and certifies lack of undisclosed material adverse information.